S56F UBA1 variant is associated with haematological predominant subtype of VEXAS
- 15 August 2023
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 203 (2) , 331-335
Abstract
No abstract availableFunding Information
- Kennedy Trust for Rheumatology Research
This publication has 7 references indexed in Scilit:
- Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS SyndromeHemaSphere, 2023
- Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationJAMA, 2023
- Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisBlood, 2022
- UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic LeukemiaHemaSphere, 2022
- Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*British Journal of Dermatology, 2021
- Genetics of somatic auto-inflammatory disordersSeminars in Hematology, 2021
- Novel somatic mutations in UBA1 as a cause of VEXAS syndromeBlood, 2021